The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli.
Connor J Haggarty, Anya K Bershad, Mahesh K Kumar, Royce Lee, Harriet de Wit
The European journal of neuroscience June 1, 2024 DOI: 10.1111/ejn.16346 via PubMed
Summary
AI-generated from the abstractMDMA, but not methamphetamine, enhances the brain's early visual processing of happy and angry facial expressions, as measured by the N170 event-related potential in an EEG oddball paradigm. This effect was specific to emotional faces compared to neutral ones. Methamphetamine did not affect this neural measure, and neither drug altered other components of the response to emotional faces. The findings suggest a unique neural mechanism for MDMA's effects on socio-emotional processing, which may underlie its therapeutic potential for social anxiety and other psychiatric disorders.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Interventions | MDMA Methamphetamine |
| Topics | MDMA |
| Keywords | EEG Faces Methamphetamine Neuroscience |
| Citations | 1 |
| Key finding | MDMA enhanced the N170 component for happy and angry faces compared to neutral faces, while methamphetamine did not affect this measure. |
Abstract
The 3,4-methylenedioxymethamphetamine (MDMA) has long been used non-medically, and it is currently under investigation for its potential therapeutic benefits. Both uses may be related to its ability to enhance empathy, sociability, emotional processing and its anxiolytic effects. However, the neural mechanisms underlying these effects, and their specificity to MDMA compared to other stimulants, are not yet fully understood. Here, using electroencephalography (EEG), we investigated the effects of MDMA and a prototypic stimulant, methamphetamine (MA), on early visual processing of socio-emotional stimuli in an oddball emotional faces paradigm. Specifically, we examined whether MDMA or MA enhance the processing of facial expressions, compared to placebo, during the early stages of visual perception. MDMA enhanced an event-related component that is sensitive to detecting faces (N170), specifically for happy and angry expressions compared to neutral faces. MA did not affect this measure, and neither drug altered other components of the response to emotional faces. These findings provide novel insights into the neural mechanisms underlying the effects of MDMA on socio-emotional processing and may have implications for the therapeutic use of MDMA in the treatment of social anxiety and other psychiatric disorders.